Profile
| Market Cap | $12.2B |
| Enterprise Value | $14.3B |
| Total Assets | $31.0B |
| Total Equity | $6.1B |
| Shares Out | 0.1B |
| Revenue (TTM) | $6.1B |
| Sector | Life & Supplemental Health |
Margins (TTM)
| Gross | -- |
| EBITDA | -- |
| Operating | -- |
| Net | 19.4% |
| FCF | -- |
Financial Health
| Total Cash | $0.3B |
| Total Debt | $2.3B |
| Net Debt | $2.1B |
| Debt/Equity | 0.4x |
| ND/EBITDA | -- |
Valuation (TTM)
| P/E | 10.8x |
| P/B | 2.0x |
| EV/Sales | 2.4x |
| P/OCF | 7.3x |
| P/FCF | n/m |
| EV/EBIT | n/m |
Deep Dive Summary
1
Read an insurer through its balance sheet and investment spread, not a retailer's margin lens: net investment income, reserve adequacy, and capital strength matter more than a single operating-margin number.
2
Statutory surplus and the regulatory solvency ratio are sourced separately and are not yet wired into this view — a known data gap, flagged in the data-quality report.